A novel use for drotrecogin alfa (activated): successful treatment of septic shock associated with coccidioidomycosis.

Nancy F. Crum; Harold L. Groff; John S. Parrish; William Ring

doi:10.1086/425918

A novel use for drotrecogin alfa (activated): successful treatment of septic shock associated with coccidioidomycosis.

Nancy F. Crum^*, Harold L. Groff, John S. Parrish, William Ring

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

We present 2 cases of septic shock associated with coccidioidomycosis that were successfully treated with drotrecogin alfa (activated) in combination with antifungal agents. The favorable outcomes, in light of the high mortality usually associated with this condition, suggest that drotrecogin alfa (activated) may be a valuable adjunct for treating septic shock due to endemic mycoses.

Original language	English
Pages (from-to)	e122-123
Journal	Clinical Infectious Diseases
Volume	39
Issue number	11
DOIs	https://doi.org/10.1086/425918
State	Published - 1 Dec 2004
Externally published	Yes

Access to Document

10.1086/425918

Cite this

@article{e1bb5f7749aa4791b3a48b6f0a665453,

title = "A novel use for drotrecogin alfa (activated): successful treatment of septic shock associated with coccidioidomycosis.",

abstract = "We present 2 cases of septic shock associated with coccidioidomycosis that were successfully treated with drotrecogin alfa (activated) in combination with antifungal agents. The favorable outcomes, in light of the high mortality usually associated with this condition, suggest that drotrecogin alfa (activated) may be a valuable adjunct for treating septic shock due to endemic mycoses.",

author = "Crum, {Nancy F.} and Groff, {Harold L.} and Parrish, {John S.} and William Ring",

year = "2004",

month = dec,

day = "1",

doi = "10.1086/425918",

language = "English",

volume = "39",

pages = "e122--123",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "11",

}

TY - JOUR

T1 - A novel use for drotrecogin alfa (activated)

T2 - successful treatment of septic shock associated with coccidioidomycosis.

AU - Crum, Nancy F.

AU - Groff, Harold L.

AU - Parrish, John S.

AU - Ring, William

PY - 2004/12/1

Y1 - 2004/12/1

N2 - We present 2 cases of septic shock associated with coccidioidomycosis that were successfully treated with drotrecogin alfa (activated) in combination with antifungal agents. The favorable outcomes, in light of the high mortality usually associated with this condition, suggest that drotrecogin alfa (activated) may be a valuable adjunct for treating septic shock due to endemic mycoses.

AB - We present 2 cases of septic shock associated with coccidioidomycosis that were successfully treated with drotrecogin alfa (activated) in combination with antifungal agents. The favorable outcomes, in light of the high mortality usually associated with this condition, suggest that drotrecogin alfa (activated) may be a valuable adjunct for treating septic shock due to endemic mycoses.

UR - http://www.scopus.com/inward/record.url?scp=28744443456&partnerID=8YFLogxK

U2 - 10.1086/425918

DO - 10.1086/425918

M3 - Article

C2 - 15578351

AN - SCOPUS:28744443456

SN - 1058-4838

VL - 39

SP - e122-123

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 11

ER -

A novel use for drotrecogin alfa (activated): successful treatment of septic shock associated with coccidioidomycosis.

Abstract

Access to Document

Fingerprint

Cite this